Suggestions
Sanjay Rakhade
Executive Medical Director at Alexion Pharmaceuticals, Inc.
Sanjay Rakhade, MD, PhD, is an accomplished drug developer and leader with a robust clinical and scientific background in clinical and translational research.
He has extensive experience in overseeing pivotal registration trials in rare disease and multiple sclerosis, as well as collaboration with health authorities.
His research expertise spans across various areas including neurology, neurosciences, genomics, pediatrics, and neonatology.
Sanjay Rakhade has been actively involved in Registrational Phase 3 trials in Rare Diseases and Multiple Sclerosis indications, as well as human disease translational trials at phase 2a and 2b levels.
He is well-versed in Good Clinical Practice (GCP) and International Conference on Harmonisation (ICH) guidelines, and proficient in adverse event reporting as per federal regulations.
Sanjay Rakhade is recognized for his versatile leadership, hands-on approach, and expertise in Technology Transfer Intellectual Property Management.
His skill set also includes strategic planning and execution, as well as team building capabilities.
Education wise, he pursued a PhD from Wayne State University School of Medicine, completed a Fellowship at Harvard Medical School, and attained his Doctor of Medicine (MD) from the University of Mumbai.
Currently, he serves as the Executive Medical Director of Clinical Development at Alexion Pharmaceuticals, Inc., showcasing his leadership in the pharmaceutical industry.
